Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24F3N3O4.ClH |
| Molecular Weight | 475.889 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(N2C[C@@H](F)[C@@H](CNC3CC3)C2)C(F)=CC4=C1N(CCF)C=C(C(O)=O)C4=O
InChI
InChIKey=YQHZQIJEMFMUGH-DFIJPDEKSA-N
InChI=1S/C21H24F3N3O4.ClH/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12;/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30);1H/t11-,16+;/m0./s1
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid. | 2019-04 |
|
| In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group. | 2018-12 |
|
| Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers. | 2018-04 |
|
| In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977). | 2017-06 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000032940
Created by
admin on Mon Mar 31 21:40:04 GMT 2025 , Edited by admin on Mon Mar 31 21:40:04 GMT 2025
|
PRIMARY | |||
|
8GYE97TPKI
Created by
admin on Mon Mar 31 21:40:04 GMT 2025 , Edited by admin on Mon Mar 31 21:40:04 GMT 2025
|
PRIMARY | |||
|
71528767
Created by
admin on Mon Mar 31 21:40:04 GMT 2025 , Edited by admin on Mon Mar 31 21:40:04 GMT 2025
|
PRIMARY | |||
|
1433857-09-0
Created by
admin on Mon Mar 31 21:40:04 GMT 2025 , Edited by admin on Mon Mar 31 21:40:04 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
